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Objectives: We evaluated the safety and eﬃcacy after hemostasis with
our locally designed Assiut femoral compression device (AFCD) ver-
sus manual compression after diagnostic coronary angiography at
Assiut University Hospitals.
Background: Previous clinical studies have indicated that FCD can be
used for achievement of hemostasis after coronary angiography (CA).
This study investigated the safety and eﬃcacy of AFCD in achieving
hemostasis after CA compared with manual compression in a cohort
of consecutive patients.
Methods: A total of 162 patients were followed after CA was per-
formed with the transfemoral approach. Univariate and multivariate
analysis were used to identify the predictors of vascular complications
with AFCD (n. 56) or with manual compression (n. 106) as a hemos-
tasis option after sheath removal.
Results: As regard safety, the use of AFCD was associated with similar
occurrence of minor bleeding compared with manual compression
(25% vs. 26%, p, 0.8). There was no signiﬁcant diﬀerence in occurrence
of major bleeding compared with manual compression (1% vs. 2%, p,
0.5). None of our patient had a pseudoaneurysm, site infection or arte-
riovenous ﬁstulae with either hemostasis technique. The use of AFCD
was associated with a more frequent occurrence of vasovagal manifes-
tation compared with manual compression (5.4% vs. 1%, p, 0.04).
As regard eﬃcacy, the device application was easy in 84% with
good ﬁxation and stability in 90% of patients. Success in complete
hemostasis was 91% with rapid learning curve. There was no diﬀerence
in total duration of compression to reach full hemostasis with AFCD
versus manual compression (13 ± 4 min vs. 12.5 ± 4 min., p, 0.4).
Conclusions: In this early experience with our locally designed AFCD
after CA, their use was associated with similar eﬃcacy and safety pro-
ﬁle compared with hemostasis using manual compression.
http://dx.doi.org/10.1016/j.ehj.2013.12.002
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Background: The link between coronary artery disease (CHD) and
chronic hepatitis C virus (HCV) infection has been shown in many
studies. However, the eﬀect of chronic HCV infection on the extent
of coronary artery disease (CAD) has not been determined so; the
aim of the present study is to determine the eﬀect of HCV infection
on the severity and the pattern of CAD in Egyptian patients.
Patients and methods: This study group included two groups of
patients with angiographically documented CAD; 25 HCV seroposi-
tive patients as test group and another 25 HCV seronegative patients
as control group. Both groups were comparable as regard, age, sex,
hypertension, and diabetes mellitus, and smoking. A detailed qualita-
tive coronary angiographic analysis and SYNTAX score were used to
assess the extent and severity of CAD.
Results: The presence of total occlusion was signiﬁcantly higher in the
HCVseropositive group (p< 0.05) and the SYNTAX score was higher
(14.86 ± 6.64 vs. 10.86 ± 7.28, p< 0.05). After adjustment, HCV
seropositivity still represented an independent predictor for severity
of coronary atherosclerosis demonstrated by higher SYNTAX score
(p< 0.05).
Conclusion: HCV infection is an independent predictor for severe cor-
onary atherosclerosis, as demonstrated by higher syntax score. It also
associated with higher incidence of totally occluded coronaries.
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